Cover Image
市場調查報告書

(EU5) 歐洲主要5個國家的壓迫療法市場:分析、預測

Compression Therapy - 5EU Analysis and Market Forecasts

出版商 GlobalData 商品編碼 357843
出版日期 內容資訊 英文 241 Pages
訂單完成後即時交付
價格
Back to Top
(EU5) 歐洲主要5個國家的壓迫療法市場:分析、預測 Compression Therapy - 5EU Analysis and Market Forecasts
出版日期: 2015年10月01日 內容資訊: 英文 241 Pages
簡介

壓迫療法產品,尤其是靜態壓迫設備,成為現在各種靜脈疾病 (深層靜脈栓塞症 (DVT)、靜脈瘤、靜脈性腳潰瘍等) 的標準治療手段。到目前為止彈性長筒襪和壓迫用繃帶等佔了市場大半,不過,近來可調整的彈性衣等急速普及,減低患者的抗拒感,對治療方法的普及有貢獻。空氣壓迫設備的技術、持續市場停滯的狀態,不過,使部分廠商進行改良幫浦設備,可對人體的各處施加各種等級的壓力。

本報告提供歐洲主要5個國家 (EU5) 的壓迫療法的市場相關分析,治療方法、相關疾病概要和基本的市場結構,已上市/臨床實驗中主要的產品的概要,全球及各地區、主要國家的市場趨勢與今後的預測,主要企業簡介等相關調查與考察。

第1章 目錄

第2章 簡介

  • 治療的趨勢
    • 全世界的趨勢
    • 各國趨勢
  • 市場進入
    • 購買意願決策
  • 品牌忠誠
  • 普及情形
  • 法規流程 (歐洲整體/各國)
  • 醫療費償付制度 (歐洲整體/各國)
  • 經濟上的影響
    • 間接的影響
    • 直接性影響

第3章 產業概要

  • 概況
  • 疾病的解剖學、病理學特徵
    • 慢性靜脈疾病
    • 靜脈瘤
    • 靜脈性腳潰瘍
    • 靜脈血栓閉塞症及深層靜脈栓塞症
    • 淋巴水腫
  • 臨床轉機
    • 靜脈疾病
    • 淋巴水腫
  • 技術的有效利用方法
    • 靜態壓迫
    • 空氣壓迫設備
  • 技術的優點和缺點
  • 市場進入
  • 臨床實驗的影響
  • 法規流程
    • 概況
    • 歐洲主要5個國家
  • 醫療費償付
    • 概況
    • 各國的詳細情況
  • 法規上的課題主要的資本交易
    • 法規上的課題和回收
    • 企業合併、收購 (M&A) 及主要企業聯盟
  • 經濟上的影響
    • 間接的影響
    • 直接性影響

第4章 未滿足需求

  • 概要
  • 患者教育的改善
  • 持續型繃帶法的普及
  • 看護者教育的擴充
  • 患者的舒適性的提高
  • 患者的可變動的的維持

第5章 市場機會分析

  • 概要
  • 彈性高的調整型服裝類的開發
  • 容易著裝的多層式長筒襪的開發
  • 附加感測器的壓迫彈性衣的改善
  • 持續治療的自動繃帶手段的開發

第6章 市場促進、阻礙因素

  • 推動因素
    • 人口高齡化
    • 癌症相關淋巴水腫
    • 肥胖率的上升
    • 發展中國家的淋巴管絲蟲症
    • 成本控制的必要性
  • 阻礙因素
    • 不完全的醫療費償付額
    • 病人依從性
    • 醫療費
    • 對醫療設備的物品稅
    • 創業投資的利用可能性
  • 替代的手段
    • 血栓閉塞症用預防治療
    • 靜脈瘤侵入性/非侵入性介入治療
    • 淋巴水腫外科的介入
    • 深層靜脈栓塞症 (DVT) 管理的藥理學性選擇

第7章 競爭分析

  • 概要
  • 主要技術、產品
  • 產品簡介 (共34家)
  • 各類型產品的SWOT分析
    • 壓迫彈性衣
    • 壓迫用繃帶
    • 血栓防止用長筒襪
    • 空氣壓迫療法

第8章 開發中產品的評估

  • 概要
  • 產品簡介 (共3產品)

第9章 值得注意的臨床實驗

  • 概要
  • 臨床實驗簡介 (共8件)

第10章 現在、未來市場參與企業

  • 概要
  • 企業簡介
    • Covidien (Medtronic)
    • Sigvaris
    • BSN Medical
    • Medi
    • Innothera
    • 3M Health Care
    • Thuasne
    • Paul Hartmann
    • Mego Afek
    • Medline Industries
    • ArjoHuntleigh (Getinge)
    • DJO Global
    • Lohmann & Rauscher
    • Venosan (Salzmann)
    • Sanyleg (Mimosa)
    • Juzo
    • Daesung Maref
    • Bio Compression Systems
    • Smith & Nephew
    • Molnlycke Health Care
    • Gloria Med
    • B. Braun
    • Alcare
    • Derma Sciences
    • Laboratoires Urgo
    • Systagenix (Acelity)
    • 村中醫療器
    • ConvaTec
    • Xiamen Senyang
    • Guangzhou Yihao Electronic Technology
    • Talley Group
    • Cardinal Health
    • Tactile Medical
    • Devon Medical
  • 目前其他的企業

第11章 市場競爭的策略性評估

  • 各企業的市場佔有率
    • 概要
    • 各地區、各企業的市場佔有率

第12章 市場未來展望:各部門

  • 各地區 (歐洲主要5個國家)

第13章 市場未來展望:各地區

  • 各地區 (歐洲主要5個國家)
  • 法國
  • 德國
  • 義大利
  • 西班牙
  • 英國

第14章 附錄

圖表一覽

目錄
Product Code: GDME1163CFR

Compression therapy products, especially static compression devices, have become the standard in the treatment of venous conditions, such as deep vein thrombosis (DVT), varicose veins, and venous leg ulcers, and lymphatic disorders, such as primary and secondary lymphedema. While elastic stockings and compression bandaging have played important roles in providing effective therapies, newer modes of static compression such as custom garments and adjustable products have been introduced to ease patient burden and improve treatment compliance. Pneumatic compression devices have similarly advanced, despite their lower adoption rates. Segmented pumps with tunable pressure characteristics have joined the ranks of simpler devices with single outputs for single inflatable chambers in the treatment of venous and lymphatic conditions. Although pneumatic compression has not quite been an arena of rapid innovation, some manufacturers have developed advanced pump systems that deliver complex pressure profiles to the affected areas of the patients' bodies. This report focuses on both static and pneumatic compression market categories. The 5EU compression therapy market has been estimated in this report, which covers the France, Germany, Italy, Spain, the UK up to 2021. The report provides an investigation of unmet needs, future adoption trends and compound annual growth rates (CAGR) for each geography and market segment. In addition, this report presents the current market drivers and barriers which will influence the future market growth of compression therapy in the 5EU region.

Highlights

Key Questions Answered

  • What is the current and future market outlook for compression therapy products in the 5EU region? What trends are affecting the global compression therapy market?
  • Which are the key, high growth markets? What compression therapy segments are growing the fastest?
  • What are the unmet needs? What is the scope for more innovation and what are the end-users looking for in their products?
  • What are some of the newer innovations that may fulfill these unmet needs? What are the physician perceptions and market outlooks?
  • What percent of global revenue are from emerging markets? How will this change in the future?
  • Sigvaris, BSN Medical, Medi, and Medtronic currently dominate the global advanced dressings market. What are their market shares in the 5EU economies and which companies constitute the remainder of the market?

Reasons to buy

  • "What Physicians Think" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading physicians and other stakeholders from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Industry Overview

  • 3.1. Overview
  • 3.2. Anatomy & Physiology
    • 3.2.1. Chronic Venous Disease
    • 3.2.2. Varicose Veins
    • 3.2.3. Venous Leg Ulcers
    • 3.2.4. Venous Thromboembolism and Deep Vein Thrombosis
    • 3.2.5. Lymphedema
  • 3.3. Clinical Outcomes
    • 3.3.1. Venous Conditions
    • 3.3.2. Lymphedema
  • 3.4. Applications of Technology
    • 3.4.1. Static Compression
    • 3.4.2. Pneumatic Compression Devices
  • 3.5. Advantages and Disadvantages of Technology
  • 3.6. Market Access
  • 3.7. Influence of Clinical Trials
  • 3.8. Regulatory Process
    • 3.8.1. Overview
    • 3.8.2. EU5
  • 3.9. Reimbursement
    • 3.9.1. Overview
    • 3.9.2. France
    • 3.9.3. Germany
    • 3.9.4. Italy
    • 3.9.5. Spain
    • 3.9.6. UK
  • 3.10. Regulatory Issue & Key Deals
    • 3.10.1. Regulatory Issues & Recalls
    • 3.10.2. Mergers, Acquisitions, and Key Partnerships
  • 3.11. Economic Impact
    • 3.11.1. Indirect Costs
    • 3.11.2. Direct Costs

4. Unmet Needs

  • 4.1. Overview
  • 4.2. Improving Patient Education
  • 4.3. Implementing Consistent Bandaging
  • 4.4. Expanding Caregiver Education
  • 4.5. Enhancing Patient Comfort
  • 4.6. Supporting Patient Mobility

5. Market Opportunity Analysis

  • 5.1. Overview
  • 5.2. Engineering Adjustable Garments for Greater Flexibility
  • 5.3. Developing Multilayer Stockings for Easier Application
  • 5.4. Improving Compression Garments by Adding Sensors
  • 5.5. Innovating Automated Bandaging for Consistent Treatment

6. Market Drivers and Barriers

  • 6.1. Drivers
    • 6.1.1. Aging Populations
    • 6.1.2. Cancer-Related Lymphedema
    • 6.1.3. Rising Rates of Obesity
    • 6.1.4. Lymphatic Filariasis in Underdeveloped Regions
    • 6.1.5. The Need for Cost Savings
  • 6.2. Barriers
    • 6.2.1. Insufficient Reimbursement
    • 6.2.2. Patient Compliance
    • 6.2.3. Cost of Care
    • 6.2.4. Medical Device Excise Tax
    • 6.2.5. Availability of Venture Capital
  • 6.3. Substitutes
    • 6.3.1. Procedures to Prevent Thromboembolism
    • 6.3.2. Invasive and Non-invasive Interventions for Varicose Veins
    • 6.3.3. Surgical Interventions for Lymphedema
    • 6.3.4. Pharmacological Options for DVT Management

7. Competitive Assessment

  • 7.1. Overview
  • 7.2. Technology and Product Offerings
  • 7.3. Product Profile
    • 7.3.1. Covidien (Medtronic)
    • 7.3.2. Sigvaris
    • 7.3.3. BSN Medical
    • 7.3.4. Medi
    • 7.3.5. Laboratoires Innothera
    • 7.3.6. 3M Health Care
    • 7.3.7. Thuasne
    • 7.3.8. Paul Hartmann
    • 7.3.9. Mego Afek
    • 7.3.10. Medline Industries
    • 7.3.11. ArjoHuntleigh
    • 7.3.12. DJO Global
    • 7.3.13. Lohmann & Rauscher
    • 7.3.14. Venosan (Salzmann)
    • 7.3.15. Sanyleg
    • 7.3.16. Juzo
    • 7.3.17. Daesung Maref
    • 7.3.18. Bio Compression Systems
    • 7.3.19. Smith & Nephew
    • 7.3.20. Molnlycke Health Care
    • 7.3.21. Gloria Med
    • 7.3.22. B. Braun
    • 7.3.23. Alcare
    • 7.3.24. Derma Sciences
    • 7.3.25. Urgo
    • 7.3.26. Systagenix
    • 7.3.27. Muranaka Medical Instruments
    • 7.3.28. ConvaTec
    • 7.3.29. Xiamen Senyang
    • 7.3.30. Guangzhou Yihao Electronic Technology
    • 7.3.31. Talley Group
    • 7.3.32. Cardinal Health
    • 7.3.33. Tactile Medical
    • 7.3.34. Devon Medical
  • 7.4. SWOT For Each Category of Device
    • 7.4.1. SWOT, Compression Garments
    • 7.4.2. SWOT, Compression Bandages
    • 7.4.3. SWOT, Anti-Embolism Stockings
    • 7.4.4. SWOT, Pneumatic Compression Therapy

8. Pipeline Assessment

  • 8.1. Overview
  • 8.2. Product Profiles
    • 8.2.1. Medical Compression Systems: ActiveCast and ActiveCare Vascular
    • 8.2.2. Epoch Medical Systems: Adaptive Compression for Lower Limb Prosthetics
    • 8.2.3. Footfalls & Heartbeats: Compression Bandage with Textile-based Sensor

9. Clinical Trials to Watch

  • 9.1. Overview
  • 9.2. Clinical Trial Profiles
    • 9.2.1. Evaluation of a Dual Action Pneumatic Compression Device
    • 9.2.2. Treatment Response to Different Lymphedema Compression Programs Using a Pneumatic Compression Device
    • 9.2.3. Two Pneumatic Compression Devices for the Treatment of Lower Extremity Lymphedema
    • 9.2.4. A Hemodynamic Comparison Study of Stationary and Portable Pneumatic Compression Devices
    • 9.2.5. DVT Prevention Study: Geko Neurosmuscular Stimulator vs. Thromboembolism Deterrent Stockings (TEDS)
    • 9.2.6. Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome
    • 9.2.7. Effectiveness of Two Compression Methods in the Treatment of Upper Limb Lymphedema
    • 9.2.8. Clinical Study to Assess Safety and Efficacy of a New Armsleeve in the Management of Arm Lymphedema

10. Current and Future Players

  • 10.1. Overview
  • 10.2. Company Profiles
    • 10.2.1. Covidien (Medtronic)
    • 10.2.2. Sigvaris
    • 10.2.3. BSN Medical
    • 10.2.4. Medi
    • 10.2.5. Innothera
    • 10.2.6. 3M Health Care
    • 10.2.7. Thuasne
    • 10.2.8. Paul Hartmann
    • 10.2.9. Mego Afek
    • 10.2.10. Medline Industries
    • 10.2.11. ArjoHuntleigh (Getinge)
    • 10.2.12. DJO Global
    • 10.2.13. Lohmann & Rauscher
    • 10.2.14. Venosan (Salzmann)
    • 10.2.15. Sanyleg (Mimosa)
    • 10.2.16. Juzo
    • 10.2.17. Daesung Maref
    • 10.2.18. Bio Compression Systems
    • 10.2.19. Smith & Nephew
    • 10.2.20. Molnlycke Health Care
    • 10.2.21. Gloria Med
    • 10.2.22. B. Braun
    • 10.2.23. Alcare
    • 10.2.24. Derma Sciences
    • 10.2.25. Laboratoires Urgo
    • 10.2.26. Systagenix (Acelity)
    • 10.2.27. Muranaka Medical Instruments
    • 10.2.28. ConvaTec
    • 10.2.29. Xiamen Senyang
    • 10.2.30. Guangzhou Yihao Electronic Technology
    • 10.2.31. Talley Group
    • 10.2.32. Cardinal Health
    • 10.2.33. Tactile Medical
    • 10.2.34. Devon Medical
  • 10.3. Other Current Players

11. Strategic Competitive Assessment

  • 11.1. Company Market Share
    • 11.1.1. Overview
    • 11.1.2. Company Share by Region

12. Market Outlooks by Market Segment

  • 12.1. By Region
    • 12.1.1. 5EU

13. Market Outlooks by Geography

  • 13.1. By Region
    • 13.1.1. 5EU
  • 13.2. France
  • 13.3. Germany
  • 13.4. Italy
  • 13.5. Spain
  • 13.6. UK

14. Appendix

  • 14.1. Bibliography
  • 14.2. Abbreviations
  • 14.3. Methodology
    • 14.3.1. Overview
    • 14.3.2. Coverage
    • 14.3.3. Secondary Research
  • 14.4. Forecasting Methodology
  • 14.5. Physicians and Specialists Included in This Study
    • 14.5.1. Key Opinion Leaders
  • 14.6. About the Authors
    • 14.6.1. Shashank Settipalli, Analyst, Medical Devices
    • 14.6.2. Priya Radhakrishnan, MBA, Director, Research and Analysis, Medical Devices
  • 14.7. About GlobalData
  • 14.8. Disclaimer

List of Tables

  • Table 1: The C Classification for Chronic Venous Conditions
  • Table 2: E, A, and P Classifications for Chronic Venous Conditions
  • Table 3: Stages of Lymphedema
  • Table 4: Covidien's Compression Therapy Marketed Products
  • Table 5: Covidien's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 6: Sigvaris Compression Therapy Marketed Products
  • Table 7: Sigvaris' Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 8: BSN Medical's Compression Therapy Marketed Products
  • Table 9: BSN Medical's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 10: Medi Compression Therapy Marketed Products
  • Table 11: Medi's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 12: Innothera's Compression Therapy Marketed Products
  • Table 13: Laboratoires Innothera's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 14: 3M Health Care's Compression Therapy Marketed Products
  • Table 15: 3M Health Care's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 16: Thuasne's Compression Therapy Marketed Products
  • Table 17: Thuasne's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 18: Paul Hartmann's Compression Therapy Marketed Products
  • Table 19: Paul Hartmann Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 20: Mego Afek's Compression Therapy Marketed Products
  • Table 21: Mego Afek's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 22: Medline's Compression Therapy Marketed Products
  • Table 23: Medline Industries' Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 24: ArjoHuntleigh Compression Therapy Marketed Products
  • Table 25: ArjoHuntleigh's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 26: DJO Global's Compression Therapy Marketed Products
  • Table 27: DJO Global's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 28: Lohmann & Rauscher's Compression Therapy Marketed Products
  • Table 29: Lohmann & Rauscher's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 30: Venosan's Compression Therapy Marketed Products
  • Table 31: Venosan's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 32: Sanyleg's Compression Therapy Marketed Products
  • Table 33: Sanyleg's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 34: Juzo's Compression Therapy Marketed Products
  • Table 35: Juzo's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 36: Daesung Maref's Compression Therapy Marketed Products
  • Table 37: Daesung Maref's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 38: Bio Compressions Systems Compression Therapy Marketed Products
  • Table 39: Bio Compression Systems' Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 40: Smith & Nephew's Compression Therapy Marketed Products
  • Table 41: Smith & Nephew's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 42: Molnlycke's Health Care Compression Therapy Marketed Products
  • Table 43: Molnlycke's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 44: Gloria Med's Compression Therapy Marketed Products
  • Table 45: Gloria Med's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 46: B. Braun Compression Therapy Marketed Products
  • Table 47: B. Braun's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 48: Alcare's Compression Therapy Marketed Products
  • Table 49: Alcare Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 50: Derma Sciences' Compression Therapy Marketed Products
  • Table 51: Derma Sciences' Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 52: Urgo's Compression Therapy Marketed Products
  • Table 53: Urgo's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 54: Systagenix's Compression Therapy Marketed Products
  • Table 55: Systagenix's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 56: Muranaka's Medical Instruments Compression Therapy Marketed Products
  • Table 57: ConvaTec Compression Therapy Marketed Products
  • Table 58: ConvaTec's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 59: Xiamen Senyang's Compression Therapy Marketed Products
  • Table 60: Xiamen Senyang's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 61: Guangzhou Yihao Electronic Technology Compression Therapy Marketed Products
  • Table 62: Guangzhou Yihao's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 63: Talley Group Compression Therapy Marketed Products
  • Table 64: Talley Group's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 65: Cardinal Health's Compression Therapy Marketed Products
  • Table 66: Cardinal Health's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 67: Tactile Medical's Compression Therapy Marketed Products
  • Table 68: Tactile Medical's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 69: Devon Medical's Compression Therapy Marketed Products
  • Table 70: Devon Medical's Compression Therapy Product Portfolio SWOT Analysis, 2015
  • Table 71: Compression Garments SWOT Analysis, 2015
  • Table 72: Compression Bandages SWOT Analysis, 2015
  • Table 73: Anti-Embolism Stockings SWOT Analysis, 2015
  • Table 74: Pneumatic Compression Therapy SWOT Analysis, 2015
  • Table 75: Covidien (Medtronic) Company Profile
  • Table 76: Covidien (Medtronic) SWOT Analysis, 2015
  • Table 77: Sigvaris Company Profile
  • Table 78: Sigvaris SWOT Analysis, 2015
  • Table 79: BSN Medical Company Profile
  • Table 80: BSN Medical SWOT Analysis, 2015
  • Table 81: Medi Company Profile
  • Table 82: Medi SWOT Analysis, 2015
  • Table 83: Innothera Company Profile
  • Table 84: Innothera SWOT Analysis, 2015
  • Table 85: 3M Company Profile
  • Table 86: 3M SWOT Analysis, 2015
  • Table 87: Thuasne Company Profile
  • Table 88: Thuasne SWOT Analysis, 2015
  • Table 89: Paul Hartmann Company Profile
  • Table 90: Paul Hartmann SWOT Analysis, 2015
  • Table 91: Mego Afek Company Profile
  • Table 92: Mego Afek SWOT Analysis, 2015
  • Table 93: Medline Company Profile
  • Table 94: Medline SWOT Analysis, 2015
  • Table 95: ArjoHuntleigh Company Profile
  • Table 96: ArjoHuntleigh SWOT Analysis, 2015
  • Table 97: DJO Global Company Profile
  • Table 98: DJO Global SWOT Analysis, 2015
  • Table 99: Lohmann & Rauscher Company Profile
  • Table 100: Lohmann & Rauscher SWOT Analysis, 2015
  • Table 101: Venosan (Salzmann) Company Profile
  • Table 102: Venosan (Salzmann) SWOT Analysis, 2015
  • Table 103: Sanyleg (Mimosa) Company Profile
  • Table 104: Sanyleg (Mimosa) SWOT Analysis, 2015
  • Table 105: Juzo Company Profile
  • Table 106: Juzo SWOT Analysis, 2015
  • Table 107: Daesung Maref Company Profile
  • Table 108: Daesung Maref SWOT Analysis, 2015
  • Table 109: Bio Compression Systems Company Profile
  • Table 110: Bio Compression Systems SWOT Analysis, 2015
  • Table 111: Smith & Nephew Company Profile
  • Table 112: Smith & Nephew SWOT Analysis, 2015
  • Table 113: Molnlycke Company Profile
  • Table 114: Molnlycke SWOT Analysis, 2015
  • Table 115: Gloria Med Company Profile
  • Table 116: Gloria Med SWOT Analysis, 2015
  • Table 117: B. Braun Company Profile
  • Table 118: B. Braun SWOT Analysis, 2015
  • Table 119: Alcare Company Profile
  • Table 120: Alcare SWOT Analysis, 2015
  • Table 121: Derma Sciences Company Profile
  • Table 122: Derma Sciences SWOT Analysis, 2015
  • Table 123: Laboratoires Urgo Company Profile
  • Table 124: Laboratoires Urgo SWOT Analysis, 2015
  • Table 125: Systagenix Company Profile
  • Table 126: Systagenix SWOT Analysis, 2015
  • Table 127: Muranaka Medical Instruments Company Profile
  • Table 128: Muranaka Medical Instruments SWOT Analysis, 2015
  • Table 129: ConvaTec Company Profile
  • Table 130: ConvaTec SWOT Analysis, 2015
  • Table 131: Xiamen Senyang Company Profile
  • Table 132: Xiamen Senyang SWOT Analysis, 2015
  • Table 133: Guangzhou Yihao Electronic Technology Company Profile
  • Table 134: Guangzhou Yihao SWOT Analysis, 2015
  • Table 135: Talley Group Company Profile
  • Table 136: Talley Group SWOT Analysis, 2015
  • Table 137: Cardinal Health Company Profile
  • Table 138: Cardinal Health SWOT Analysis, 2015
  • Table 139: Tactile Medical Company Profile
  • Table 140: Tactile Medical SWOT Analysis, 2015
  • Table 141: Devon Medical Company Profile
  • Table 142: Devon Medical SWOT Analysis, 2015
  • Table 143: Other Current Players
  • Table 144: EU5 Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Table 145: France Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Table 146: France Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Table 147: Germany Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Table 148: Germany Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Table 149: Italy Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Table 150: Italy Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Table 151: Spain Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Table 152: Spain Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Table 153: UK Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Table 154: UK Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021

List of Figures

  • Figure 1: Virchow's Triad
  • Figure 2: 5EU Company Market Shares for Static Compression Therapy, 2014
  • Figure 3: 5EU Company Market Shares for Pneumatic Compression Therapy, 2014
  • Figure 4: 5EU Market Value Forecast by Market Segment for Compression Therapy, 2011-2021
  • Figure 5: 5EU Compression Therapy Market Share Comparison by Country, 2014 and 2021
  • Figure 6: France Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Figure 7: France Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Figure 8: Germany Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Figure 9: Germany Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Figure 10: Italy Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Figure 11: Italy Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Figure 12: Spain Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Figure 13: Spain Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
  • Figure 14: UK Market Value Forecast by Market Segment for Compression Therapy, $m, 2011-2021
  • Figure 15: UK Market Value Forecast by Market Segment for Static Compression Therapy, $m, 2011-2021
Back to Top